Abstract
The goal of the present review is to characterise the induction profile of CYP2C9, a member of the cytochrome P450 superfamily. Since the mechanism of CYP2C9 induction is fairly complex, with parallel processes triggered by various inducers, an evaluation of the experimental results is often a great challenge. At least three nuclear receptors, the glucocrticoid receptor (GR), the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), are known to mediate the CYP2C9 gene induction in man. However, mathematical modelling and simulation can provide an appropriate tool for the interpretation of CYP2C9 regulatory mechanisms. As an example, we present modelling and simulation approaches of the CYP2C9 gene expression in human hepatocytes treated with wellknown CYP2C9 inducers: the steroid hormone precursor dehydroepiandrosterone (DHEA) and the synthetic glucocorticoid dexamethasone (DXM). The results of the analysis suggest that in addition to the potent function of GR and the further involvement of PXR and CAR activated by DXM or DHEA, an additional factor might play a role in CYP2C9 regulation by DHEA. The novel potential candidate for DHEA action in CYP2C9 induction is likely to be the estrogen receptor. Additionally, the balance of DHEA sulphation-desulphation processes should also be considered in any description of DHEA-induced CYP2C9 profiles.
Keywords: CYP2C9, estrogen receptor, dehydroepiandrosterone, dexamethasone, nuclear receptors, mathematical modelling, simulation, dynamical systems
Current Drug Metabolism
Title: Investigation of the CYP2C9 Induction Profile in Human Hepatocytes by Combining Experimental and Modelling Approaches
Volume: 10 Issue: 10
Author(s): Ales Belic, Manna Temesvari, Krisztina Kohalmy, Radim Vrzal, Zdenek Dvorak, Damjana Rozman and Katalin Monostory
Affiliation:
Keywords: CYP2C9, estrogen receptor, dehydroepiandrosterone, dexamethasone, nuclear receptors, mathematical modelling, simulation, dynamical systems
Abstract: The goal of the present review is to characterise the induction profile of CYP2C9, a member of the cytochrome P450 superfamily. Since the mechanism of CYP2C9 induction is fairly complex, with parallel processes triggered by various inducers, an evaluation of the experimental results is often a great challenge. At least three nuclear receptors, the glucocrticoid receptor (GR), the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), are known to mediate the CYP2C9 gene induction in man. However, mathematical modelling and simulation can provide an appropriate tool for the interpretation of CYP2C9 regulatory mechanisms. As an example, we present modelling and simulation approaches of the CYP2C9 gene expression in human hepatocytes treated with wellknown CYP2C9 inducers: the steroid hormone precursor dehydroepiandrosterone (DHEA) and the synthetic glucocorticoid dexamethasone (DXM). The results of the analysis suggest that in addition to the potent function of GR and the further involvement of PXR and CAR activated by DXM or DHEA, an additional factor might play a role in CYP2C9 regulation by DHEA. The novel potential candidate for DHEA action in CYP2C9 induction is likely to be the estrogen receptor. Additionally, the balance of DHEA sulphation-desulphation processes should also be considered in any description of DHEA-induced CYP2C9 profiles.
Export Options
About this article
Cite this article as:
Belic Ales, Temesvari Manna, Kohalmy Krisztina, Vrzal Radim, Dvorak Zdenek, Rozman Damjana and Monostory Katalin, Investigation of the CYP2C9 Induction Profile in Human Hepatocytes by Combining Experimental and Modelling Approaches, Current Drug Metabolism 2009; 10 (10) . https://dx.doi.org/10.2174/138920009790820147
| DOI https://dx.doi.org/10.2174/138920009790820147 |
Print ISSN 1389-2002 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Innovative Therapeutic Approaches in Infectious Diseases
Infectious diseases continue to challenge global health systems due to rising antimicrobial resistance, emerging pathogens, and increasing drug tolerance. This special issue aims to move beyond traditional approaches by exploring innovative pharmacological strategies for the treatment of infectious diseases. We welcome original research and reviews ranging from clinical trials and ...read more
Pharmacokinetics of Nanocarriers: Challenges, Innovations, and Translational Perspectives
This thematic issue will focus on the evolving field of nanocarrier-based drug delivery systems and their pharmacokinetic behavior. Understanding the ADME (Absorption, Distribution, Metabolism, and Excretion) properties of nanoparticles is crucial for optimizing therapeutic efficacy and minimizing systemic toxicity. The issue will highlight the influence of nanocarrier physicochemical properties (size, ...read more
Unveil the Potential of Functional Framework Nucleic Acids in Theranostics
Nanomedicine demonstrates remarkable potential in disease diagnosis and treatment by precisely manipulating the physicochemical properties of materials on the nanometer scale. Its advantages as nanocarriers include high loading capacity, prolonged in vivo half-life and controllable targeted delivery. However, existing vectors (such as liposomes, polymers, and inorganic particles) still face significant ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prevalence of Analgesic Use and Pain in People with and without Dementia or Cognitive Impairment in Aged Care Facilities: A Systematic Review and Meta-Analysis
Current Clinical Pharmacology PET Imaging of MRP1 Function in the Living Brain: Method Development and Future Perspectives
Current Topics in Medicinal Chemistry Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Biomedical Applications of Hydroxyapatite Nanoparticles
Current Pharmaceutical Biotechnology Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry Anatomical, Biochemical and Physiological Considerations of the Colon in Design and Development of Novel Drug Delivery Systems
Current Drug Delivery Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare
Current Medicinal Chemistry Monitoring of Environmental Metals in Human Blood: The Need for Data Validation
Current Analytical Chemistry Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics
Recent Patents on Biomarkers 21.1 Tesla Magnetic Resonance Imaging Apparatus and Image Interpretation: First Report of a Scientific Advancement
Recent Patents on Medical Imaging Bone Marrow Reconstitution as a Relevant Model of Genetically Programmed Leukemia
Current Medicinal Chemistry - Cardiovascular & Hematological Agents A Discussion Regarding the Application of the Hertz Contact Theory on Biological Samples in AFM Nanoindentation Experiments
Micro and Nanosystems Doripenem: A New Addition to the Carbapenem Class of Antimicrobials
Recent Patents on Anti-Infective Drug Discovery DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Clinical and Translational Research Challenges in Neuroendocrine Tumours
Current Medicinal Chemistry Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Current Psychiatry Reviews Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
Current Medicinal Chemistry Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets





